TG Therapeutics, Inc. (TGTX)
30.57
-0.14
(-0.46%)
USD |
NASDAQ |
Jan 16, 16:00
30.04
-0.53
(-1.73%)
After-Hours: 06:52
TG Therapeutics Total Liabilities (Quarterly): 417.81M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 638.39M |
| MannKind Corp. | 539.19M |
| Karyopharm Therapeutics, Inc. | 365.49M |
| Axsome Therapeutics, Inc. | 595.52M |
| Krystal Biotech, Inc. | 102.22M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.025B |
| Shareholders Equity (Quarterly) | 607.22M |
| Debt to Equity Ratio | 0.4178 |
| Current Ratio | 3.825 |
| Net Debt Paydown Yield | -0.50% |